E. Polge

G. Mufti, M. Labopin, D. Blaise, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT.

A. Ganser, N. Kröger, M. Labopin, 2013, Blood.

Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation.

N. Kröger, M. Labopin, A. Nagler, 2012, Blood.

Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Esteve, C. Craddock, M. Labopin, 2017, Haematologica.

Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT 3-ITD ; a study from the Acute Leukemia Working

J. Esteve, C. Craddock, M. Labopin, 2017 .

Long‐term outcome after a treosulfan‐based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

M. Labopin, A. Nagler, M. Mohty, 2017, Cancer.

Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study.

Christoph Schmid, Jordi Esteve, Roni Shouval, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation

J. Bourhis, M. Labopin, D. Blaise, 2019, Cancer.

Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT

M. Labopin, A. Nagler, M. Mohty, 2016, Journal of Hematology & Oncology.

The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation – a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR

A. Nagler, M. Mohty, K. Hsu, 2018, Bone Marrow Transplantation.

Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT

A. Ganser, M. Labopin, I. Yakoub-Agha, 2021, Blood Cancer Journal.

A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation.

Arnon Nagler, Myriam Labopin, Francesco Frassoni, 2008, Blood.

Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.

M. Labopin, A. Nagler, E. Holler, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP)

J. Esteve, M. Labopin, J. Finke, 2005, Leukemia.

Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.

S. Montoto, N. Kröger, M. Labopin, 2019, The Lancet. Haematology.

Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT database

M. Labopin, I. Yakoub-Agha, A. Nagler, 2016, Haematologica.

Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study

M. Labopin, D. Blaise, A. Nagler, 2018, American journal of hematology.

Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of ⩾10 years

M. Labopin, P. Chevallier, A. Nagler, 2015, Bone Marrow Transplantation.

Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT).

A. Baruchel, G. Leverger, G. Dini, 2005, Blood.

Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT

J. Esteve, M. Labopin, J. Finke, 2016, Bone Marrow Transplantation.

A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality

M. Labopin, M. Mohty, G. Socié, 2014, Bone Marrow Transplantation.

Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse

M. Labopin, A. Nagler, M. Mohty, 2018, JAMA oncology.

Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT

M. Labopin, A. Nagler, M. Mohty, 2018, American journal of hematology.

Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network

M. Grce, H. Greinix, A. Barata, 2022, Bone Marrow Transplantation.

Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation.

J. Esteve, J. Bourhis, F. Baron, 2015, Blood.

Autologous transplant remains the preferred therapy for relapsed APL in CR2

J. Esteve, A. Nagler, M. Mohty, 2016, Bone Marrow Transplantation.

Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission

J. Esteve, M. Labopin, P. Chevallier, 2018, American journal of hematology.

Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell transplantation

M. Labopin, D. Blaise, J. Reiffers, 2003, Leukemia.

ATG or no ATG? – survey of clinical practice in EBMT centers on behalf of the Transplant Complications Working Party of EBMT

G. Basak, I. Moiseev, A. Piekarska, 2022, Bone Marrow Transplantation.

Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center

J. Esteve, M. Labopin, P. Chevallier, 2018, Cancer.

Influence of pretransplant inflammatory bowel disease on the outcome of allogeneic hematopoietic stem cell transplantation: a matched-pair analysis study from the Transplant Complications Working Party (TCWP) of the EBMT

N. Kröger, C. Crawley, N. Russell, 2021, Bone Marrow Transplantation.

Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study

M. Labopin, D. Blaise, M. Mohty, 2016, Haematologica.

Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.

M. Labopin, G. Meloni, L. Fouillard, 2004, Haematologica.

Working Parties

M. Labopin, P. Chevallier, A. Nagler, 2015, Bone Marrow Transplantation.

(EBMT) study of the European Group for Blood and Marrow Transplantation Hematopoietic stem cell transplantation for de novo erythroleukemia: a

M. Labopin, R. Willemze, G. Meloni, 2013 .

Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT).

M. Labopin, R. Willemze, G. Meloni, 2002, Blood.

A haploidentical may be a better choice than a female genoidentical donor to transplant a patient with high risk acute myelogenous leukemia in first remission

J. Bourhis, M. Labopin, D. Blaise, 2019 .

M. Labopin, D. Blaise, M. Mohty, 2023, Journal of Hematology & Oncology.

Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK‐NUP214 shows a favourable outcome when performed in first complete remission

J. Esteve, J. Sierra, M. Labopin, 2020, British journal of haematology.

Frequency of lethal central nervous system neurotoxicity in patients undergoing allogeneic stem cell transplantation: a retrospective registry analysis

N. Kröger, D. Blaise, G. Basak, 2019, Bone Marrow Transplantation.

Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years—a registry-based study by the Acute Leukemia Working Party of the EBMT

J. Bourhis, M. Labopin, P. Chevallier, 2023, Bone Marrow Transplantation.

Post remission consolidation by autologous HCT for AML in CR1, negative implications for subsequent allogeneic HCT in CR2. A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).

M. Labopin, I. Yakoub-Agha, D. Blaise, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association Between the Hematopoietic Cell Transplantation-Specific Comorbidity Index (CI) and Non-Relapse Mortality (NRM) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1).

N. Kröger, M. Labopin, D. Blaise, 2009 .

University of Birmingham Allogeneic stem cell transplantation benefits for patients 60 years with acute myeloid leukemia and FLT3 internal tandem duplication:

J. Esteve, M. Labopin, P. Chevallier, 2018 .

Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis.

M. Labopin, A. Nagler, M. Mohty, 2015, The Lancet. Haematology.

Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation.

N. Kröger, M. Labopin, A. Nagler, 2012, Blood.

CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT.

A. Ganser, N. Kröger, M. Labopin, 2013, Blood.

Characterization of loose and tight dimer forms of avian leukosis virus RNA.

J. Darlix, P. Fossé, J. Paoletti, 2000, Journal of molecular biology.

Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study

J. Bourhis, M. Mohty, U. Salmenniemi, 2023, Bone Marrow Transplantation.

Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation.

J. Esteve, J. Bourhis, F. Baron, 2015, Blood.

Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party

A. Ganser, P. Dreger, J. Passweg, 2022, Journal for ImmunoTherapy of Cancer.